Jobs
View more job listings or post a job
InnoAlliance Scientist/Sr Scientist of Bioanalysis & Biomarkers
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Post a job

Workshop

[Free Online] Patient Centric Blood Sampling for Facilitating De-centralized Clinical Trials: Implications for ClinOps, PK/ClinPharm, Bioanalytical and Biomarkers


Speakers: Brian Booth, FDA; Jeff Silverman, Edgewise Therapeutics; Mitch Johnson, Veloxity Labs, LLC; Sally Fischer, Genentech, Inc.; Katty Wan, Pfizer; Jeff Plomley, Altasciences
Organizers: Robyn Rourick, Genentech; Neil Spooner, Spooner Bioanalytical Solutions
Date: 2024-10-17
Time: 8:30-12:00 Pacific Time
Registration fee: Free
Location: Zoom
Major Sponsor: (2)RedDrop Dx; Veloxity Labs
Vendor show vendors registered to date: (5)Altasciences; Alturas Analytics; Celerion; Q² Solutions; Tasso, Inc.
Registration: http://www.PBSS.org
Registration deadline:2024-10-16  (it will close sooner if the seating cap is reached)

About the Topic

Attendees of this half day digital workshop will learn about patient centric blood sampling and how it has been applied for decentralized clinical trials, through a number of case studies. Patient Centric Sampling (PCS) is an approach to enable the collection of high quality blood samples in a location that is more convenient to the patient, for example, at home versus a centralized clinic. Samples can be self collected, or by a caregiver and can be used for the determination of PK of administered drug and metabolites, as well as measuring concentrations of biomarkers and for the determination of clinical chemistry endpoints. PCS brings a number of advantages including the potential for increased patient recruitment and retention, the ability to expand clinical trial recruitment to rural areas and underserved communities, facilitating pediatric studies and studies with vulnerable populations.

Topics to be covered:

  • Overview of  Patient Centric Sampling - technologies, applications and benefits

  • Regulatory considerations for including PCS approaches in clinical trials

  • Implications and considerations for clinical operations, PK/ClinPharm, bioanalytical, etc.

  • Case studies highlighting how PCS has been used for clinical trials

Major Sponsor: Veloxity, and RedDrop Dx

Regular Sponsors: Altasciences, Alturas Analytics, Celerion, Tasso, and Q2 Solutions.


About the Speakers

Brian Booth, Director, FDA

Jeff Silverman, Senior Research Fellow, Edgewise Therapeutics

Mitch Johnson, Laboratory Director, Veloxity Labs, LLC

Sally Fischer, Sr. Director/Sr. Fellow, Genentech, Inc.

Katty Wan, Sr. Director, Pfizer

Jeff Plomley, Scientific Director, Altasciences


2024-10-01, [In-Person] DMPK/Clinical Pharmacology for IND/NDA Filings
2024-10-17, [Free Online by PBSS-San Diego] Patient Centric Blood Sampling for Facilitating De-centralized Clinical Trials: Implications for ClinOps, PK/ClinPharm, Bioanalytical and Biomarkers
©Pharmaceutical & BioScience Society, International; Last Modified: 7/25/2024; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Simulations Plus GastroPlus X: Science, models & refined algorithms—now with intuitive interface, faster processing & streamlined workflows for faster PBPK modeling.
Submit a Text Ad